Veradermics Incorporated (MANE)
MANE trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$116.26
-5.02% on the day
Market cap
$4.9B
Mid cap
Revenue
Recent IPO: no annual report filed yet
Net income
Recent IPO: no annual report filed yet
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | MANE on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2026 |
| SEC CIK | 0001827635 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Recent IPO: no annual report filed yet.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-08-14 |
| Latest annual report | 10-K | 2026-03-30 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-08-11 |
Source: SEC EDGAR submissions feed, 96 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +3.0% |
| 1 month | +10.0% |
| 3 months | +8.0% |
| Year to date | Not enough price history |
| 1 year | Not enough price history |
| From 52-week high | -12.7% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| COGT | Cogent Biosciences Inc. | $28.09 | -5.67% | $4.9B |
| TVTX | Travere Therapeutics Inc. | $51.80 | -0.42% | $4.9B |
| GRFS | Grifols S.A. | $7.17 | -2.71% | $4.9B |
| PTCT | PTC Therapeutics Inc. | $59.92 | -4.77% | $5.0B |
| ERAS | Erasca Inc. | $14.78 | -4.40% | $5.2B |
| MIRM | Mirum Pharmaceuticals Inc. | $79.62 | -7.48% | $5.2B |
| DNTH | Dianthus Therapeutics Inc. | $77.58 | -4.89% | $4.3B |
| INDV | Indivior Pharmaceuticals Inc. | $35.42 | -1.77% | $4.2B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier